AFP and hepatocellular carcinoma: AFP can activate the PI3K/AKT signalling, stimulates the transcription cofactor mTOR, STAT3, HIF‐1α and Bcl‐2, which regulates the expression of oncogenes, as well as promotes angiogenesis and the growth of the hepatoma cells.